ValueQ4, 24Q1, 25Q2, 25Q3, 25TTMSelling/general/admin expenses1.98 B2.2 B2.07 B2.03 B8.28 BResearch & development—————영업 이익1.59 B1.04 B1.41 B1.62 B5.65 BNon-Operating Income, Total-31 M64 M62 M74 M169 MInterest expense, net of interest capitalized45 M49 M74 M63 M231 MNon-Operating Income, excl. Interest Expenses195 M15 M-12 M11 M209 MUnusual income/expense-271 M————Pretax income1.51 B1.05 B1.4 B1.63 B5.59 BEquity in earnings52 M————Taxes209 M220 M232 M380 M1.04 BNon-controlling/minority interest46 M47 M53 M64 M210 MAfter tax other income/expense-213 M-57 M-112 M-40 M-422 MNet income before discontinued operations1.26 B784 M1.11 B1.19 B4.34 BDiscontinued operations0————Net income1.26 B784 M1.11 B1.19 B4.34 BDilution adjustment—————Preferred dividends—————Diluted net income available to common stockholders1.26 B784 M1.11 B1.19 B4.34 BBasic earnings per share (Basic EPS)9.966.288.959.6334.82Diluted earnings per share (Diluted EPS)9.96.258.929.5934.66Average basic shares outstanding127.4 M124.9 M124 M123.2 M499.5 MDiluted shares outstanding128.1 M125.5 M124.4 M123.7 M501.7 MEBITDA1.74 B1.19 B1.59 B1.81 B6.34 BEBIT1.59 B1.04 B1.41 B1.62 B5.65 BCost of revenue87.18 B94.55 B99.61 B102.47 B383.81 BOther cost of goods sold—————Depreciation & amortization (cash flow)151 M157 M188 M188 M684 M
McKesson Corporation
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.